These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.


BIOMARKERS

Molecular Biopsy of Human Tumors

- a resource for Precision Medicine *

950 related articles for article (PubMed ID: 22306361)

  • 21. Sublingual immunotherapy is not always a safe alternative to subcutaneous immunotherapy.
    Cochard MM; Eigenmann PA
    J Allergy Clin Immunol; 2009 Aug; 124(2):378-9. PubMed ID: 19541352
    [No Abstract]   [Full Text] [Related]  

  • 22. How to design and evaluate randomized controlled trials in immunotherapy for allergic rhinitis: an ARIA-GA(2) LEN statement.
    Bousquet J; Schünemann HJ; Bousquet PJ; Bachert C; Canonica GW; Casale TB; Demoly P; Durham S; Carlsen KH; Malling HJ; Passalacqua G; Simons FE; Anto J; Baena-Cagnani CE; Bergmann KC; Bieber T; Briggs AH; Brozek J; Calderon MA; Dahl R; Devillier P; Gerth van Wijk R; Howarth P; Larenas D; Papadopoulos NG; Schmid-Grendelmeier P; Zuberbier T
    Allergy; 2011 Jun; 66(6):765-74. PubMed ID: 21496059
    [TBL] [Abstract][Full Text] [Related]  

  • 23. [Allergic rhinitis: pathology of general interest].
    Incorvaia C; Barbera S; Makrì E; Mauro M
    Recenti Prog Med; 2013 Mar; 104(3):116-9. PubMed ID: 23548956
    [TBL] [Abstract][Full Text] [Related]  

  • 24. The health economics of allergen immunotherapy.
    Hankin CS; Cox L; Bronstone A
    Immunol Allergy Clin North Am; 2011 May; 31(2):325-41, x. PubMed ID: 21530823
    [TBL] [Abstract][Full Text] [Related]  

  • 25. [Allergia rhinosinusitis. Diagnosis, programming and treatment monitoring].
    Obtułowicz K; Składzień J
    Przegl Lek; 2005; 62(12):1475-9. PubMed ID: 16786777
    [TBL] [Abstract][Full Text] [Related]  

  • 26. Prevention of allergic disease in childhood: clinical and epidemiological aspects of primary and secondary allergy prevention.
    Halken S
    Pediatr Allergy Immunol; 2004 Jun; 15 Suppl 16():4-5, 9-32. PubMed ID: 15125698
    [TBL] [Abstract][Full Text] [Related]  

  • 27. Allergen immunotherapy: present and future.
    Finegold I
    Allergy Asthma Proc; 2007; 28(1):44-9. PubMed ID: 17390757
    [TBL] [Abstract][Full Text] [Related]  

  • 28. One century of allergen-specific immunotherapy for respiratory allergy.
    Incorvaia C; Frati F
    Immunotherapy; 2011 May; 3(5):629-35. PubMed ID: 21554092
    [TBL] [Abstract][Full Text] [Related]  

  • 29. Advances in upper airway diseases and allergen immunotherapy in 2007.
    Saltoun C; Avila PC
    J Allergy Clin Immunol; 2008 Sep; 122(3):481-7. PubMed ID: 18694591
    [TBL] [Abstract][Full Text] [Related]  

  • 30. Possible relationship between systemic side effects and sensitization to rPar j 2 in allergic patients submitted to an ultra-rush (20 min) sublingual immunotherapy and selected by component resolved diagnosis.
    Rossi RE; Monasterolo G; Coco G; Operti D
    Int Arch Allergy Immunol; 2005 Oct; 138(2):105-10. PubMed ID: 16174987
    [TBL] [Abstract][Full Text] [Related]  

  • 31. [How to manage allergic rhinitis in current practice].
    Eloit C; Marmouz F
    Allerg Immunol (Paris); 2001 Dec; 33(10):406-8. PubMed ID: 11802483
    [TBL] [Abstract][Full Text] [Related]  

  • 32. Multiallergen-specific immunotherapy in polysensitized patients: where are we?
    Bahceciler NN; Galip N; Cobanoglu N
    Immunotherapy; 2013 Feb; 5(2):183-90. PubMed ID: 23413909
    [TBL] [Abstract][Full Text] [Related]  

  • 33. Survey on the impact of comorbid allergic rhinitis in patients with asthma.
    Valovirta E; Pawankar R
    BMC Pulm Med; 2006 Nov; 6 Suppl 1(Suppl 1):S3. PubMed ID: 17140421
    [TBL] [Abstract][Full Text] [Related]  

  • 34. Identification and management of undiagnosed and undertreated allergic rhinitis in adults and children.
    Stewart MG
    Clin Exp Allergy; 2008 May; 38(5):751-60. PubMed ID: 18419620
    [TBL] [Abstract][Full Text] [Related]  

  • 35. Do indications to sublingual immunotherapy need to be revised?
    Incorvaia C; Mauro M
    J Allergy Clin Immunol; 2010 Jan; 125(1):277; author reply 277-8. PubMed ID: 20109757
    [No Abstract]   [Full Text] [Related]  

  • 36. Subcutaneous versus sublingual immunotherapy for allergic rhinitis and/or asthma.
    Bahceciler NN; Cobanoglu N
    Immunotherapy; 2011 Jun; 3(6):747-56. PubMed ID: 21668312
    [TBL] [Abstract][Full Text] [Related]  

  • 37. Age and indications to SLIT.
    Terracciano L; Calcinai E; Avitabile S; Galli E
    Int J Immunopathol Pharmacol; 2009; 22(4 Suppl):5-8. PubMed ID: 19944002
    [TBL] [Abstract][Full Text] [Related]  

  • 38. Clinical bystander effect exerted by allergen immunotherapy: a hypothesis.
    Ciprandi G
    Eur Ann Allergy Clin Immunol; 2015 Mar; 47(2):62-3. PubMed ID: 25781197
    [TBL] [Abstract][Full Text] [Related]  

  • 39. Identifying the culprit allergen in seasonal allergic rhinitis.
    Vaitla PM; Drewe E
    Practitioner; 2011 May; 255(1740):27-31, 2. PubMed ID: 21714475
    [TBL] [Abstract][Full Text] [Related]  

  • 40. Allergen immunotherapy and health care cost benefits for children with allergic rhinitis: a large-scale, retrospective, matched cohort study.
    Hankin CS; Cox L; Lang D; Bronstone A; Fass P; Leatherman B; Wang Z
    Ann Allergy Asthma Immunol; 2010 Jan; 104(1):79-85. PubMed ID: 20143650
    [TBL] [Abstract][Full Text] [Related]  

    [Previous]   [Next]    [New Search]
    of 48.